tiprankstipranks
Acumen Pharmaceuticals (ABOS)
NASDAQ:ABOS
US Market

Acumen Pharmaceuticals (ABOS) Technical Analysis

317 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
7Bullish
0Neutral
5Bearish
Acumen Pharmaceuticals’s (ABOS) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Acumen Pharmaceuticals is a Sell.
Acumen Pharmaceuticals’s (ABOS) 20-Day exponential moving average is 3.52, while Acumen Pharmaceuticals’s (ABOS) share price is $3.65, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) 50-Day exponential moving average is 3.58, while Acumen Pharmaceuticals’s (ABOS) share price is $3.65, making it a Buy.

Acumen Pharmaceuticals (ABOS) Pivot Points

May 18, 2024, 07:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.55
3.64
3.68
3.77
3.81
3.90
3.94
Fibonacci
3.64
3.69
3.72
3.77
3.82
3.85
3.90
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Acumen Pharmaceuticals (ABOS) Moving Averages

May 18, 2024, 07:38 AM
Period
Simple
Exponential
MA5
3.65Buy
3.65Buy
MA10
3.55Buy
3.57Buy
MA20
3.40Buy
3.52Buy
MA50
3.71Sell
3.58Buy
MA100
3.68Sell
3.67Sell
MA200
3.91Sell
4.14Sell
Acumen Pharmaceuticals’s (ABOS) 10-Day exponential moving average is 3.57, while Acumen Pharmaceuticals’s (ABOS) share price is $3.65, making it a Buy.
Acumen Pharmaceuticals’s (ABOS) 100-Day exponential moving average is 3.67, while Acumen Pharmaceuticals’s (ABOS) share price is $3.65, making it a Sell.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.65 and Acumen Pharmaceuticals’s (ABOS) 50-day simple moving average is 3.71, creating a Sell signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.65 and Acumen Pharmaceuticals’s (ABOS) 100-day simple moving average is 3.68, creating a Sell signal.
Acumen Pharmaceuticals’s (ABOS) stock price is $3.65 and Acumen Pharmaceuticals’s (ABOS) 200-day simple moving average is 3.91, creating a Sell signal.

Acumen Pharmaceuticals (ABOS) Technical Indicators

May 18, 2024, 07:38 AM
Name
Value
Implied Action
RSI (14)
54.17
Neutral
STOCH (9,6)
68.04
Neutral
STOCHRSI (14)
75.13
Neutral
MACD (12,26)
0.02
Sell
ADX (14)
20.09
Neutral
Williams %R
-34.84
Buy
CCI (14)
96.33
Neutral
ATR (14)
0.22
-
Ultimate Oscillator
45.51
Neutral
ROC
14.78
Buy
Acumen Pharmaceuticals’s (ABOS) Relative Strength Index (RSI) is 54.17, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Trend Strength Indicator (ADX) is 20.09, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Commodity Channel Index (CCI) is 96.33, creating a Neutral signal.
Acumen Pharmaceuticals’s (ABOS) Price Rate of Change (ROC) is 14.78, creating a Buy signal.

FAQ

Is ABOS a Buy, Hold, or Sell?
Based on ABOS’s technical indicators, ABOS is a Buy.
    What is ABOS’s RSI (14)?
    ABOS’s RSI (14) is 54.17, which suggests ABOS is a Neutral.
      What is ABOS’s MACD?
      ABOS’s MACD is 0.02, which suggests ABOS is a Sell.
        What is ABOS’s 5-day moving average?
        ABOS’s 5-day moving average is 3.65, which suggests ABOS is a Buy.
          What is ABOS’s 20-day moving average?
          ABOS 20-day moving average is 3.40, which suggests ABOS is a Buy.
            What is ABOS’s 50-day moving average?
            ABOS’s 50-day moving average is 3.71, which suggests ABOS is a Sell.
              What is ABOS’s 200-day moving average?
              ABOS’s 200-day moving average is 3.91, which suggests ABOS is a Sell.
                What is ABOS’s Williams % R (14)?
                ABOS’s Williams % R (14) is -34.84, which suggests ABOS is a Buy.
                  What is ABOS’s CCI (14)?
                  ABOS’s CCI (14) is 96.33, which suggests ABOS is a Neutral.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis